STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -44.75% | -10.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -44.75% | -10.52% | |||
| Cost of Revenue | -13.93% | -2.38% | |||
| Gross Profit | -53.79% | -12.66% | |||
| SG&A Expenses | -1.63% | -7.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.29% | -4.83% | |||
| Operating Income | -584.23% | -51.93% | |||
| Income Before Tax | -330.52% | 27.34% | |||
| Income Tax Expenses | 22.49% | 7.58% | |||
| Earnings from Continuing Operations | -442.97% | 35.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -442.97% | 35.25% | |||
| EBIT | -584.23% | -51.93% | |||
| EBITDA | -439.28% | -44.33% | |||
| EPS Basic | -442.60% | 35.02% | |||
| Normalized Basic EPS | -330.14% | 27.15% | |||
| EPS Diluted | -447.40% | 33.33% | |||
| Normalized Diluted EPS | -332.65% | 27.53% | |||
| Average Basic Shares Outstanding | 0.14% | 0.15% | |||
| Average Diluted Shares Outstanding | -0.94% | -0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||